default image

Urologie

Information and services of the department

  • Number of inpatient cases: 416

Services search (in the department)


Illness Number of cases
Malignant neoplasm of prostate (C61) 57
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) 42
Hyperplasia of prostate (N40) 42
Other specified abnormalities of plasma proteins (R77.80) 34
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) 22
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 21
Calculus of kidney and ureter - Calculus of kidney (N20.0) 17
Calculus of kidney and ureter - Calculus of ureter (N20.1) 14
Other disorders of urinary system - Urinary tract infection site not specified (N39.0) 14
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 11
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 176
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 75
Dilatation of the ureters during an operation or endoscopy (5-560.2) 73
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 70
Injection or administration of medicines into the urinary bladder (8-132.2) 64
(5-98k.0) 50
Insertion, exchange or removal of a ureteral stent (8-137.00) 50
Examination of the urethra and the urinary bladder by endoscopy (1-661) 46
(1-466.00) 44
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) 44

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung 0
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
49 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
37 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
28 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
No. Training in other healing professions Comment
HB19 Nursing professionals Dreijährig examiniertes Pflegepersonal
HB17 Auxiliary nurse (m/f) Einjährig examiniertes Pflegepersonal

Herr Gunnar Schramm

Klinikgeschäftsführer

Phone: 09372 -700-1000
Mail: ed.tiehdnuseg-soileh@mmarhcS.rannuG

Frau Natascha Breunig

Qualitätsmanagement

Phone: 09372 -700-1065
Mail: ed.tiehdnuseg-soileh@hcabnelrE.gnunieM

Frau Sandra Kern

MKT

Phone: 09372 -700-1006
Mail: ed.tiehdnuseg-soileh@hcabnelrE.gnunieM

Frau Natascha Breunig

Qualitätsmanagementbeauftragte

Phone: 09372 -700-1065
Mail: ed.tiehdnuseg-soileh@ginuerB.ahcsataN

Ärztlicher Direktor / Herr Chefarzt Dr. Michael Weberpals

Vorsitzender

Phone: 09372 -700-1920
Mail: ed.tiehdnuseg-soileh@slaprebeW.leahciM

Herr Peter Sattler

Abteilungsleiter Apotheke

Phone: 0611 -43-3673
Mail: ed.tiehdnuseg-soileh@relttaS.reteP